Due to the strong synergistic effects observed between WEE1 inhibitors and G12C inhibitors in in vitro cell models, we further validated the efficacy and safety of the combination strategy involving WEE1i and G12Ci in xenograft tumor models in vivo. This evidence concerns the gene WEE1 and neoplasm.